Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wenzhou Kangning Hospital Co's revenue for the
six
months ended in Jun. 2026 was €106.3 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was €213.1 Mil.
Wenzhou Kangning Hospital Co's Revenue per Share for the
six
months ended in Jun. 2026 was €1.51.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was €3.01.
During the past 12 months, the average Revenue per Share Growth Rate of Wenzhou Kangning Hospital Co was 18.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 3.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 7.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 14.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 12 years, Wenzhou Kangning Hospital Co's highest 3-Year average Revenue per Share Growth Rate was 27.00% per year. The lowest was 3.70% per year. And the median was 15.10% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Wenzhou Kangning Hospital Co Revenue Related Terms
Wenzhou Kangning Hospital Co Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Wenzhou Kangning Hospital Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wenzhou Kangning Hospital Co Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Wenzhou Kangning Hospital Co's Revenue distribution charts can be found below:
* The bar in red indicates where Wenzhou Kangning Hospital Co's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €213.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wenzhou Kangning Hospital Co (FRA:4WK) has a Revenue of €213.1 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Wenzhou Kangning Hospital Co and its competitors.
Is Wenzhou Kangning Hospital Co's Revenue too high?
Wenzhou Kangning Hospital Co's current Revenue is €213.1 Mil. Overall, Wenzhou Kangning Hospital Co has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Wenzhou Kangning Hospital Co's Revenue compare to HCA and THC?
Wenzhou Kangning Hospital Co's Revenue of €213.1 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Wenzhou Kangning Hospital Co and its competitors. Wenzhou Kangning Hospital Co's current Revenue is €213.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wenzhou Kangning Hospital Co stock overvalued right now?
Wenzhou Kangning Hospital Co (FRA:4WK) has a current Revenue of €213.1 Mil. The stock's GF Value™ is €1.35, compared to a current price of €0.94 — trading 30.7% below its estimated fair value. The current Revenue is €213.1 Mil. Wenzhou Kangning Hospital Co's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Wenzhou Kangning Hospital Co (FRA:4WK), the current Revenue is €213.1 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wenzhou Kangning Hospital Co (FRA:4WK) Overvalued in 2026?
Based on GuruFocus' analysis, Wenzhou Kangning Hospital Co stock appears to be undervalued.
The current stock price of €0.94 is trading 30.7% below its estimated GF Value™ of €1.35.
Key valuation signals for FRA:4WK:
Revenue: €213.1 Mil
GF Value™: €1.35 vs. price of €0.94 (30.7% below fair value)
No single metric tells the full story. See the FRA:4WK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wenzhou Kangning Hospital Co Ltd is engaged in operating a network of healthcare facilities that focus on providing psychiatric specialty care and elderly rehabilitation service across various regions in China. It derives revenue from operating its owned hospitals consists of fees charged for outpatient visits and inpatient services at the group's various hospitals, which can be divided into treatment and general healthcare services and pharmaceutical sales, as well as variable considerations for medical services provided by the group, mainly including medical insurance settlement differences.
75GF Score
Get the complete analysis for FRA:4WK
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4WK has been successfully added to your 
